Equity
€102,421 from €553,112 in 2016
Equity fell by 81% in 9 years.
BIO CONSULTING
Lifetime
13 annual accounts with figures on one time axispeak €284,717 (2018)
€120,245▼ 19.7%
lowest -€59,270 (2019)
€7,073▼ 83.0%
peak €553,112 (2016)
€102,421▲ 7.4%
€1.1m▼ 5.3%
peak 0.5 FTE (2016)
-not published
Board1 name since 2021
1 directorBIONDO Sebastien
Owners2 names in the annual accounts
Documentsfilings and deeds
22-06-202639 days before the deadline
2025micro format
Gross margin from €149,656 to €120,245Result from €41,538 to €7,073
Key points
from the 2025 annual accountsDebts
€1.1m 92% of the balance sheet
Financial debts 90%Suppliers 1%Taxes and wages 3%Other 6%
Of this, €125,100 falls due within a year.
Position in the sector
8.3%
Lower solvency than 82% of companies in advertising and market research. Sector median 53.3% · 8,615 companies.
Checked score
91
Excellent
Financially stronger than 39% of micro companies in advertising and market research (NACE 73)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: 0.2% across 11,231 companies (NACE 73, micro).
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.2%
01-2025: 0.2%● unchanged vs 12-2024
02-2025: 0.2%● unchanged vs 01-2025
03-2025: 0.2%● unchanged vs 02-2025
04-2025: 0.2%● unchanged vs 03-2025
05-2025: 0.3%▲ +0.1 percentage points vs 04-2025
06-2025: 0.3%● unchanged vs 05-2025
07-2025: 0.4%▲ +0.1 percentage points vs 06-2025highest value
08-2025: 0.1%▼ -0.3 percentage points vs 07-2025
09-2025: 0.1%● unchanged vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.1%● unchanged vs 01-2026
03-2026: 0.1%● unchanged vs 02-2026
04-2026: 0.1%● unchanged vs 03-2026
05-2026: 0.2%▲ +0.1 percentage points vs 04-2026
06-2026: 0.2%● unchanged vs 05-2026
07-2026: 0.1%▼ -0.1 percentage points vs 06-2026lowest value
08-2026: 0.1%● unchanged vs 07-2026lowest value
09-2026: 0.1%● unchanged vs 08-2026lowest value
10-2026: 0.1%● unchanged vs 09-2026lowest value
11-2026: 0.1%● unchanged vs 10-2026lowest value
Financial strengthAverage
Score breakdown
raises risk
Equity €102,421 (8.3% of total assets)
lowers risk
Size: total assets €1.2m
Figures for financial year 2025 (filed on 22-06-2026)
Founded in 2012
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 73, micro). It does better than 19% of them on solvency, 53% on liquidity, 29% on profitability and 57% on growth.
The bankruptcy probability was computed on 10-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 1,448 companies had the same profile as BIO CONSULTING has now. Each dot stands for 4 companies, two years later.
95.6%
were still trading
2.1%
stopped another way
2.0%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of BIO CONSULTING itself is lower: 0.1% within 12 months. It rests on far more data about BIO CONSULTING than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,448 companies, not a prediction for BIO CONSULTING. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €9,000 on 30-day terms is acceptable
Liquidity is tight, with a current ratio of 1.03 (1.12 in 2024), below the usual 1.5. Short-term debt is 10.2% and cash 8.5% of total assets. 91.7% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Seven signals.
lowers riskraises riskneutral
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 17% of 8615 sector peers (2025).
NBB · sector comparisonPosition among 8615 sector peers
Solvency
better than 17%
← weakest
strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025Equity per financial year
1819202122232425
2018 to 2025 · latest year €102,421
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 22-06-2026, 39 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
39 days early
2024
15 days early
2023
28 days early
2022
7 days early
2021
31 days late
2020
60 days late
2019
90 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 7 accounts on average 13 days after the deadline. In the sector (NACE 73), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 16 July (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
11-11-2026 today31-12-2026 year end31-07-2027 deadline
Board and ownership
- Sébastien BIONDO 99%annual accounts 2018
- Astrid MUYLAERT 1%annual accounts 2018
Shares in 1 company, SOCLOTHES
Board & ownershipRecent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0843979677
Reappointment: BIONDO Sebastien (director)
General meeting of 21-04-2023 · Gazette deed
Capital decrease · Amendment of the articles
Capital from €505,000 to €492,600 · Capital from €492,600 to €50,000 · General meeting of 05-12-2017 · Gazette deed
Registered office moved from Uccle to Lasne
New registered office: Le Grand Closin, 10 1380 Lasne · Previous registered office: Rue Lincoln 45 à 1180 Uccle · Board meeting of 28-04-2017 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| BIO CONSULTING Lasne | €1.2m | €120,245 | 8.3% | - |
| DL@Consulting Frameries | €1.3m | €128,897 | 41.3% | - |
| M.B. BEHEER Tongeren-Borgloon | €1.2m | €140,002 | 76.5% | - |
| NDV-INVEST Beernem | €1.1m | €102,873 | 20.2% | 0 |
| K2M Consulting Hasselt | €1.1m | €109,045 | 40.1% | - |
| DE JONGE MANAGEMENT Overijse | €1.1m | €141,861 | 5.2% | - |
| CreFin Tongeren-Borgloon | €1.2m | €120,327 | 70.9% | - |
These companies have the same main activity as BIO CONSULTING: public relations and communication consultancy (NACE 73300). They are comparable in size and age: total assets between €1.1m and €1.3m, founded between 2010 and 2012.
Official details
Source: KBO- Status
- Active since 24-02-2012Normal situation
- Activity
- Public relations and communication consultancyNACE 73300and 4 others
- Establishment unit
- 2.208.215.4901380 Lasne, since 24-02-2012
- Financial year end
- 31 December
- Peppol
- Reachable since 24-11-2023
Annual accounts 2025
- ≈ €220,000estimated
- €1.2m▼ 4.4%
- ≈ 0.6 FTEestimated
- Filing
- Filed on 22-06-2026, 39 days before the end of the filing period
Insights on BIO CONSULTING
BIO CONSULTING files the micro format. That format states no turnover. The gross margin rose from €100,576 in 2013 to €120,245 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about BIO CONSULTING
- What is the company number of BIO CONSULTING?
- The company number of BIO CONSULTING is 0843.979.677. The VAT number is the same number with BE in front: BE 0843.979.677.
- Where is BIO CONSULTING based?
- The registered office is at Le Grand Closin 10, 1380 Lasne.Company details
- What does BIO CONSULTING do?
- According to the KBO register, the main activity is public relations and communication consultancy (NACE 73300).
- What is the legal form of BIO CONSULTING?
- BIO CONSULTING is a private limited company (BV).
- When was BIO CONSULTING founded?
- BIO CONSULTING was founded on 24-02-2012.
- Is BIO CONSULTING still active?
- Yes, BIO CONSULTING is an active enterprise in the KBO register.
- How many employees does BIO CONSULTING have?
- BIO CONSULTING had an average of 1 full-time equivalents in financial year 2023, according to the filed annual accounts.Financials
- What is the turnover of BIO CONSULTING?
- The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €120,245 and 38 comparable companies (NACE 73). It probably lies between €170,000 and €440,000.
- Is BIO CONSULTING profitable?
- In financial year 2025, BIO CONSULTING made a profit of €7,073.
- Where can I find the annual accounts of BIO CONSULTING?
- BIO CONSULTING filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of BIO CONSULTING due?
- BIO CONSULTING must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.